Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an IV drip replace the needle for arthritis patients?

NCT ID NCT07290036

Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study compares two ways of giving the drug bimekizumab to people with active psoriatic arthritis or axial spondyloarthritis: as an IV infusion or as a shot under the skin. The goal is to see if the IV method works just as well as the shot. About 392 adults who are suitable for bimekizumab treatment will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

About 392 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Be 18+ years old and legally able to consent 2. Have active psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), suitable for bimekizumab treatment 3. Weigh between 45-100 kg (females) or 50-100 kg (males). 4. Be biologic disease-modifying anti-rheumatic drug (bDMARD)-naïve or have stopped bDMARDs ≥3 months or 5 half-lives ago Exclusion Criteria: 1. Serious organ system disorders (e.g., heart, liver, kidney, gastrointestinal, neuro) 2. Severe psychiatric issues or substance abuse in the past year 3. Recent or chronic infections, including tuberculosis (TB) or nontuberculous mycobacterium (NTMB) 4. Other inflammatory diseases (e.g., rheumatoid arthritis (RA), lupus, inflammatory bowel disease (IBD)) 5. Recent live vaccines (within 8 weeks) or Bacillus Calmette-Guerin (BCG) (within 1 year) 6. Recent use of glucagon-like peptide-1 (GLP-1) agonists (within 28 weeks)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Axial spondyloarthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Axial Spondyloarthritis psoriatic arthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Axial spondyloarthritis Psoriatic arthritis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    63 sites in 6 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Pa0019 111

    RECRUITING

    Covina, California, 91722, United States

  • Pa0019 113

    RECRUITING

    South Miami, Florida, 33155, United States

  • Pa0019 114

    RECRUITING

    Peoria, Arizona, 85381-5025, United States

  • Pa0019 115

    RECRUITING

    Duncansville, Pennsylvania, 16635, United States

  • Pa0019 116

    RECRUITING

    Jackson, Tennessee, 38305, United States

  • Pa0019 117

    RECRUITING

    Riverside, California, 92518, United States

  • Pa0019 119

    RECRUITING

    Fullerton, California, 92835, United States

  • Pa0019 120

    RECRUITING

    Whittier, California, 90602, United States

  • Pa0019 121

    RECRUITING

    Bellevue, Washington, 98004, United States

  • Pa0019 123

    RECRUITING

    Fort Collins, Colorado, 80528, United States

  • Pa0019 124

    RECRUITING

    Plano, Texas, 75075, United States

  • Pa0019 125

    RECRUITING

    San Leandro, California, 94578, United States

  • Pa0019 126

    RECRUITING

    Temecula, California, 92592, United States

  • Pa0019 127

    RECRUITING

    Apple Valley, California, 92307, United States

  • Pa0019 128

    RECRUITING

    Whittier, California, 90602, United States

  • Pa0019 129

    RECRUITING

    Baytown, Texas, 77521, United States

  • Pa0019 130

    RECRUITING

    Beckley, West Virginia, 25801, United States

  • Pa0019 131

    RECRUITING

    Albuquerque, New Mexico, 87102, United States

  • Pa0019 132

    RECRUITING

    Chicago, Illinois, 60661, United States

  • Pa0019 133

    RECRUITING

    Zephyrhills, Florida, 33542, United States

  • Pa0019 134

    RECRUITING

    Lansing, Michigan, 48911, United States

  • Pa0019 135

    RECRUITING

    Mesquite, Texas, 75150, United States

  • Pa0019 136

    RECRUITING

    Colleyville, Texas, 76034, United States

  • Pa0019 138

    RECRUITING

    Murfreesboro, Tennessee, 37128, United States

  • Pa0019 140

    RECRUITING

    West Long Branch, New Jersey, 07764-1503, United States

  • Pa0019 141

    RECRUITING

    Upland, California, 91786, United States

  • Pa0019 142

    RECRUITING

    Rock Hill, South Carolina, 29732, United States

  • Pa0019 143

    RECRUITING

    Ormond Beach, Florida, 32174, United States

  • Pa0019 144

    RECRUITING

    Vandalia, Ohio, 45377, United States

  • Pa0019 145

    RECRUITING

    Spokane, Washington, 99216, United States

  • Pa0019 201

    RECRUITING

    Plovdiv, Bulgaria

  • Pa0019 202

    RECRUITING

    Plovdiv, Bulgaria

  • Pa0019 203

    RECRUITING

    Plovdiv, Bulgaria

  • Pa0019 204

    RECRUITING

    Lovech, Bulgaria

  • Pa0019 205

    RECRUITING

    Pleven, Bulgaria

  • Pa0019 301

    RECRUITING

    Hamburg, Germany

  • Pa0019 302

    RECRUITING

    Ratingen, Germany

  • Pa0019 305

    RECRUITING

    Berlin, Germany

  • Pa0019 306

    RECRUITING

    Wetzlar, Germany

  • Pa0019 401

    RECRUITING

    Elblag, Poland

  • Pa0019 402

    RECRUITING

    Lodz, Poland

  • Pa0019 404

    RECRUITING

    Bytom, Poland

  • Pa0019 405

    RECRUITING

    Warsaw, Poland

  • Pa0019 406

    RECRUITING

    Poznan, Poland

  • Pa0019 407

    RECRUITING

    Bialystok, Poland

  • Pa0019 408

    RECRUITING

    Poznan, Poland

  • Pa0019 409

    RECRUITING

    Warsaw, Poland

  • Pa0019 410

    RECRUITING

    Lublin, Poland

  • Pa0019 411

    RECRUITING

    Poznan, Poland

  • Pa0019 412

    RECRUITING

    Krakow, Poland

  • Pa0019 413

    RECRUITING

    Nowa Sól, Poland

  • Pa0019 414

    RECRUITING

    Warsaw, Poland

  • Pa0019 415

    RECRUITING

    Płońsk, Poland

  • Pa0019 416

    RECRUITING

    Torun, Poland

  • Pa0019 417

    RECRUITING

    Olsztyn, Poland

  • Pa0019 418

    RECRUITING

    Bialystok, Poland

  • Pa0019 420

    RECRUITING

    Wroclaw, Poland

  • Pa0019 601

    RECRUITING

    Košice, Slovakia

  • Pa0019 603

    RECRUITING

    Piešťany, Slovakia

  • Pa0019 702

    RECRUITING

    Uherské Hradiště, Czechia

  • Pa0019 703

    RECRUITING

    Hlučín, Czechia

  • Pa0019 704

    RECRUITING

    Ostrava, Czechia

  • Pa0019 705

    RECRUITING

    Brno, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.